{
    "clinical_study": {
        "@rank": "161489", 
        "arm_group": {
            "arm_group_label": "Caspofungin 70 mg", 
            "arm_group_type": "Other", 
            "description": "Infusion of one dose of Caspofungin 70 mg"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to conduct a population pharmacokinetic analysis of\n      caspofungin in a population of patients with moderate and severe acute alcoholic hepatitis\n      or liver disease with Child-Pugh score B and C in order to better characterize\n      pharmacokinetic parameters in case of moderate and severe liver dysfunction."
        }, 
        "brief_title": "Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Bacterial Infections and Mycoses", 
            "Liver Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bacterial Infections", 
                "Liver Diseases", 
                "Mycoses", 
                "Liver Failure"
            ]
        }, 
        "detailed_description": {
            "textblock": "patients admitted for alcoholic hepatitis or decompensated cirrhosis and Child-Pugh score\n      7-9 and 10-15 will be included; all patients without invasive aspergillosis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Liver failure Child-Pugh B and C\n\n        Exclusion Criteria:\n\n          -  Cachexia (BMI < 15 kg/m\u00b2)\n\n          -  Pregnancy\n\n          -  HIV\n\n          -  Hepatitis C patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01968395", 
            "org_study_id": "E2013_PK_CASPO70_LIVERFAILURE"
        }, 
        "intervention": {
            "arm_group_label": "Caspofungin 70 mg", 
            "description": "Intravenous use", 
            "intervention_name": "Caspofungin 70 mg", 
            "intervention_type": "Drug", 
            "other_name": "Cancidas"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Caspofungin", 
                "Echinocandins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 23, 2013", 
        "location": {
            "contact": {
                "email": "frederique.jacobs@erasme.ulb.ac.be", 
                "last_name": "Fr\u00e9d\u00e9rique JACOBS, MD, PhD", 
                "phone": "+3225553111", 
                "phone_ext": "4433"
            }, 
            "facility": {
                "address": {
                    "city": "Brussels", 
                    "country": "Belgium", 
                    "zip": "1070"
                }, 
                "name": "Erasme University Hospital"
            }, 
            "investigator": {
                "last_name": "Fr\u00e9d\u00e9rique JACOBS, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure", 
        "overall_contact": {
            "email": "frederique.jacobs@erasme.ulb.ac.be", 
            "last_name": "Fr\u00e9d\u00e9rique JACOBS, MD, PhD", 
            "phone": "+3225553111", 
            "phone_ext": "4433"
        }, 
        "overall_contact_backup": {
            "email": "rudy.surin@erasme.ulb.ac.be", 
            "last_name": "Rudy SURIN, SCo", 
            "phone": "+3225553111", 
            "phone_ext": "5807"
        }, 
        "overall_official": {
            "affiliation": "Erasme University Hospital", 
            "last_name": "Fr\u00e9d\u00e9rique JACOBS, MD,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "one dose of caspofungin will be given to patients with hepatic failure. Serum sampling will be performed during 96 hours. Measurements of caspofungin in the serum will be performed to study the pharmacokinetics of this drugs and will be compared with pharmacokinetics of subjects with normal liver function. For safety, patients will be followed during 14 days.", 
            "measure": "Measurement of serum caspofungine concentrations to determine the pharmacokinetic parameters of Caspofungin in patients with liver failure", 
            "safety_issue": "Yes", 
            "time_frame": "14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01968395"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Erasme University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Erasme University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}